Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Microbiology & Infectious Diseases
Filter
Journals
About
Congress reviews
Abstracts
Articles
Interviews
Podcasts
Videos & Webinars
News
Infographics
Society updates
Submit A Paper
Single HPV Vaccine Dose Matches Two-Dose Protection
November 2026
A major trial finds one HPV vaccine dose provides protection comparable to two doses, with over 97% effectiveness against high-risk HPV infections.
Read more
17 Nov 2026
Single HPV Vaccine Dose Matches Two-Dose Protection
A major trial finds one HPV vaccine dose provides protection comparable to two doses, with over 97% effectiveness against high-risk HPV infections.
17 Nov 2026
Cefazolin Reduces Kidney Injury in Bloodstream Infections
Cefazolin matches standard antibiotics for survival in MSSA bloodstream infections while significantly reducing the risk of acute kidney injury.
16 Nov 2026
Antibiotic-Resistant Bloodstream Infections Rise 17% in England
Antibiotic-resistant bloodstream infections in England have risen 17% since 2019, with new UKHSA data revealing growing resistance and health inequalities.
15 Nov 2026
What’s Holding Back Antimicrobial Stewardship?
New research identifies economic pressures, education gaps, and conflicting expectations as key barriers to appropriate antimicrobial use in human and animal health.
14 Nov 2026
New Antimicrobial Candidate Targets Drug-Resistant TB
Researchers identify valepotriate as a promising new compound against drug-resistant tuberculosis, demonstrating rapid bactericidal activity in laboratory tests.
12 Nov 2026
Hepatitis C Coinfection Linked to Liver Risk in HIV: HIV Glasgow 2026
Hepatitis C coinfection was the strongest independent risk factor for serious liver outcomes among 9,595 people in the Swiss HIV Cohort Study.
11 Nov 2026
Statin Use Rises but Gaps Persist in HIV Care: HIV Glasgow 2026
Statin use rose from 29% to 46% among people with HIV at very high cardiovascular risk in a Dutch cohort, according to data from HIV Glasgow 2026.
10 Nov 2026
African Study Finds Dolutegravir Resistance: HIV Glasgow 2026
A Lesotho HIV cohort found dolutegravir resistance in 9.9% of tested patients who met WHO criteria for virological failure.
Loading posts...
1
2
3
…
56
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View